| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 01/30/2013 | CN101974378B Method for improving foaming characteristic of draught beer |
| 01/30/2013 | CN101928740B MMP14 double-target efficient binding peptide, method for obtaining polypeptide structure sequence and application of target compound |
| 01/30/2013 | CN101831441B Escherichia coli engineering bacteria for expressing recombinant CrylC genes |
| 01/29/2013 | US8362231 RNA interference mediating small RNA molecules |
| 01/29/2013 | US8362226 Thermophilic and thermoacidophilic sugar transporter genes and enzymes from Alicyclobacillus acidocaldarius and related organisms, methods |
| 01/29/2013 | US8362214 Antibodies that bind human dendritic and epithelial cell 205 (DEC-205) |
| 01/29/2013 | US8362213 Anti-FcRH5 antibodies and immunoconjugates and methods of use |
| 01/29/2013 | US8362211 Anti-CD38 antibodies |
| 01/29/2013 | US8362210 Antibody variants with enhanced complement activity |
| 01/29/2013 | US8362208 Immunoglobulins |
| 01/29/2013 | US8361774 Recombinant type II restriction endonuclease, NmeAIII, and a process for producing the same |
| 01/29/2013 | US8361773 Polynucleotides encoding polypeptides and host cells therefor |
| 01/29/2013 | US8361770 Genetically programmed expression of selectively sulfated proteins in Eubacteria |
| 01/29/2013 | US8361769 Regioselective alkane hydroxylation with a mutant CYP153A6 enzyme |
| 01/29/2013 | US8361767 BGL7 beta-glucosidase and nucleic acids encoding the same |
| 01/29/2013 | US8361761 Process for preparing dipeptidyl peptidase IV inhibitors and intermediates therefor |
| 01/29/2013 | US8361752 Artificial scaffolding material for protein retention and use of the same |
| 01/29/2013 | US8361751 Cells in which activity of the protein involved in transportation of GDP-fucose is reduced or lost |
| 01/29/2013 | US8361750 rBSA from K. lactis expression, secretion and purification of recombinant bovine serum albumin (rBSA) from K. lactis and uses thereof |
| 01/29/2013 | US8361749 Process for preparing variant of Erysipelothrix rhusiopathiae surface protective antigen in E. coli |
| 01/29/2013 | US8361748 Method for producing α-L-aspartyl-L-phenylalanine-β-ester and method for producing α-L-aspartyl-L-phenylalanine-α-methyl ester |
| 01/29/2013 | US8361747 Antibodies against human angiopoietin 2 |
| 01/29/2013 | US8361746 Methods for detection of methyl-CpG dinucleotides |
| 01/29/2013 | US8361744 Methods and composition for secretion of heterologous polypeptides |
| 01/29/2013 | US8361711 Tools and methods useful in characterising the immunotoxic activity of xenobiotic substances |
| 01/29/2013 | US8361474 Anti-IL-12 antibody based vectors, host cells, and methods of production and uses |
| 01/29/2013 | US8361466 Tweak receptor |
| 01/29/2013 | US8361465 Use of anti-sphingosine-1-phosphate antibodies in combination with chemotherapeutic agents |
| 01/29/2013 | US8361463 Humanized antibodies against human interferon-alpha |
| 01/29/2013 | US8361461 Anti-IGF-IR antibodies and uses thereof |
| 01/29/2013 | CA2700180C Modifying glycoprotein production in plants |
| 01/29/2013 | CA2557295C Improved bacterial host cell for the direct expression of peptides |
| 01/29/2013 | CA2522645C New monoclonal antibody capable of binding integrin alpha10beta1 |
| 01/29/2013 | CA2482995C Low-cost production of peptides |
| 01/29/2013 | CA2477975C Novel vip3 toxins and methods of use |
| 01/29/2013 | CA2462113C Multi-chain eukaryotic display vectors and uses thereof |
| 01/29/2013 | CA2431891C Mutations in neuronal gene sodium-channel alpha 1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus |
| 01/29/2013 | CA2325574C Porcine adenovirus type 3 genome |
| 01/24/2013 | WO2013013019A2 Lysosomal polypeptides, methods of making and using |
| 01/24/2013 | WO2013013017A2 Compositions and methods for modifying the glycosylation of lysosomal storage disorder therapeutics |
| 01/24/2013 | WO2013012022A1 Stable protein-containing preparation containing argininamide or analogous compound thereof |
| 01/24/2013 | WO2011134919A3 Cho cells cultivation process 0 |
| 01/24/2013 | US20130024956 Antibodies to cd40 |
| 01/24/2013 | US20130023653 Tissue Specific Expression Of Antibodies In Chickens |
| 01/24/2013 | US20130023647 Modified human thymic stromal lymphopoietin |
| 01/24/2013 | US20130023476 Pharmaceutical Preparation Comprising Recombinant HCG |
| 01/24/2013 | US20130023459 Method for Preparing a Protein Emulsion |
| 01/24/2013 | US20130023009 Method for specifically producing a joined dna fragment comprising a sequence derived from a target gene |
| 01/24/2013 | US20130022957 Enhanced animal cell growth using ultrasound |
| 01/24/2013 | US20130022631 Vaccine for chikungunya virus infection |
| 01/24/2013 | US20130022624 Anti-epidermal growth factor receptor antibodies and uses thereof |
| 01/24/2013 | US20130022616 Interleukin-31 Monoclonal Antibody |
| 01/24/2013 | US20130022606 Neutralizing prolactin receptor antibodies and their therapeutic use |
| 01/24/2013 | US20130022605 Antagonists against tnfr1 and methods of use therefor |
| 01/23/2013 | EP2548967A2 Aldehyde tags, uses thereof in site-specific protein modification |
| 01/23/2013 | EP2548579A1 Targeting VEGF-B regulation of fatty acid transporters to modulate human diseases |
| 01/23/2013 | EP2548578A1 Targeting VEGF-B regulation of fatty acid transporters to modulate human diseases |
| 01/23/2013 | EP2548458A1 Lupine-derived compounds having hypotensive activity and process for production of their production |
| 01/23/2013 | EP2547781A1 Method of producing transcripts using cryptic splice sites |
| 01/23/2013 | CN102892886A Axmi218, axmi219, axmi220, axmi226, axmi227, axmi228, axmi229, axmi230, and axmi231 delta-endotoxin genes and methods for their use |
| 01/23/2013 | CN102892883A Gene encoding lignan methyltransferase, and use thereof |
| 01/23/2013 | CN102892787A Radioactive metal-labeled anti-cadherin antibody |
| 01/23/2013 | CN102888436A Effervescent tablet type low molecular weight collagen peptide and preparation method thereof |
| 01/23/2013 | CN102888435A Method for producing soy peptone by using isolated soy protein substrate |
| 01/23/2013 | CN102888434A Process of extracting collagen from waste chrome leather scraps |
| 01/23/2013 | CN102888275A Methods for extracting Badam oil and proteins |
| 01/23/2013 | CN102887953A Anti-abeta antibodies and their use |
| 01/23/2013 | CN102887947A Process for producing micromolecule hemepeptide, heme iron and plasma proteins by using duck blood as raw material |
| 01/23/2013 | CN102887940A Bioactive peptide prepared from shellfish processing byproducts and preparation method thereof |
| 01/23/2013 | CN102002105B Gene, expression vector, expression method, expression cell and application of human papilloma virus (HPV) 16 E7E6 fusion protein |
| 01/23/2013 | CN101967192B Fusion protein of anti-CD20 antibody fragment and lidamycin (LDM) as well as preparation method and application thereof |
| 01/23/2013 | CN101948895B New method for development and utilization of potato residue resource |
| 01/23/2013 | CN101906456B Preparation method of antioxidant peptide derived from mytilus coruscus |
| 01/23/2013 | CN101775427B Method for regulating microorganism metabolism lipopeptid compound composition |
| 01/23/2013 | CN101111599B Expression carrier used for treating bacterial infection |
| 01/22/2013 | US8357791 DNA and proteins or peptides specific of bacteria of the Neisseria meningitidis species, methods for obtaining them and biological applications thereof |
| 01/22/2013 | US8357781 Neuroactive fragments of APP |
| 01/22/2013 | US8357779 Polymer-von Willebrand factor-conjugates |
| 01/22/2013 | US8357535 PURO-DHFR quadrifunctional marker and its use in protein production |
| 01/22/2013 | US8357532 Expanding the eukaryotic genetic code |
| 01/22/2013 | US8357531 Immortalized avian cell lines |
| 01/22/2013 | US8357529 Using nutrient broth containing escherichia to translated preferential messenger RNA sequences |
| 01/22/2013 | US8357515 Latency associated protein construct with aggrecanase sensitive cleavage site |
| 01/22/2013 | US8357514 Methods of gene amplification and expression |
| 01/22/2013 | US8357511 Protein purification tags and uses thereof |
| 01/22/2013 | US8357509 Microbial expression of tobacco osmotin for biocidal and medical applications |
| 01/22/2013 | US8357503 Hydrolases, nucleic acids encoding them and methods for making and using them |
| 01/22/2013 | US8357424 Preparation of nanoparticle chains comprising reacting of functional groups |
| 01/22/2013 | US8357371 Methods for treating hypercholesterolemia using antibodies to PCSK9 |
| 01/22/2013 | US8357370 Anti-D monoclonal antibodies |
| 01/22/2013 | US8357365 Granulysin peptides and methods of use thereof |
| 01/22/2013 | CA2622074C Rapid production of high titer virus |
| 01/22/2013 | CA2589657C Production of .beta.-glucosidase, hemicellulase and ligninase in e1 and flc-cellulase-transgenic plants |
| 01/22/2013 | CA2536735C Methods for determining cd8+ t-cell epitopes |
| 01/22/2013 | CA2441663C Viral vectors and their use in therapeutic methods |
| 01/22/2013 | CA2343716C Contortrostatin (cn) and methods for its use in preventing metastasis and other conditions |
| 01/22/2013 | CA2329267C A method of modulating the efficiency of translation termination and degradation of aberrant mrna involving a surveillance complex comprising human upflp, eucaryotic release factor 1 and eucaryotic release factor 3 |
| 01/17/2013 | WO2013009948A2 Novel zinc finger-like peptide compositions as potent agents in cancer prevention and treatment |
| 01/17/2013 | WO2013009868A1 Compositions and methods for making selenocysteine containing polypeptides |
| 01/17/2013 | WO2013009648A2 Cell culture process |